Skip to main content

Table 3 Mutual relationships among TME protein expressions

From: PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas

 

PD-L1 in TICs

 

PD-1+ TICs

 

VEGF in TCs

 

CD4+ TICs

 

CD8+ TICs

 

CD68+ TICs

 
 

High expression (n = 36)

Low expression (n = 185)

P-value

High density (n = 131)

Low density (n = 90)

P-value

High expression (n = 151)

Low expression (n = 70)

P-value

High density (n = 117)

Low density (n = 104)

P-value

High density (n = 43)

Low density (n = 178)

P-value

High density (n = 129)

Low density (n = 92)

P-value

High PD-L1 expression in TCs

18 (50%)

137 (74%)

0.0054

88 (67%)

67 (74%)

0.30

102 (68%)

53 (76%)

0.27

86 (74%)

69 (66%)

0.30

33 (77%)

122 (69%)

0.36

88 (68%)

67 (73%)

0.55

High PD-L1 expression in TICs

–

–

–

31 (24%)

5 (6%)

0.00032

29 (19%)

7 (10%)

0.12

24 (21%)

12 (12%)

0.10

19 (44%)

17 (10%)

6.4E-07

30 (23%)

6 (7%)

0.00078

High density of PD-1+ TICs

–

–

–

–

–

–

86 (57%)

45 (64%)

0.38

76 (65%)

55 (53%)

0.076

33 (77%)

98 (55%)

0.0097

90 (70%)

41 (45%)

0.00028

High VEGF expression in TCs

–

–

–

–

–

–

–

–

–

76 (65%)

75 (72%)

0.31

33 (77%)

118 (66%)

0.21

88 (68%)

63 (68%)

1.0

High density of CD4+ TICs

–

–

–

–

–

–

–

–

–

–

–

–

32 (74%)

85 (48%)

0.0020

77 (60%)

40 (43%)

0.020

High density of CD8+ TICs

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

32 (25%)

11 (12%)

0.024

  1. Abbreviations: TME tumor microenvironment, PD-L1 programmed cell death-ligand 1, TICs tumor-infiltrating immune cells, PD-1 programmed cell death-1, VEGF vascular endothelial growth factor, TCs tumor cells